Skip to main content
Caplight Logo









Kiyatec

Kiyatec

Private
Greenville, South CarolinaHealthcare & Life Scienceshttps://kiyatec.com/

Last Round

Strategic

Nov 13, 2025

Total Funding Raised

$31.73M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kiyatec is a functional precision oncology company that provides clinical testing and preclinical drug development services using proprietary 3D cell culture technology to predict patient-specific responses to cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

3D cell cultureprecision oncologyex vivo testingtumor profilingcontract research organizationCROdrug development servicespatient-derived tumor modelsfunctional drug testingorganoid technologypreclinical researchclinical trial supportdrug response predictionlab servicesbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kiyatec Comparables

Compare Kiyatec with similar companies based on industry and business-model similarity.

Kiyatec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spanios
84%
Certis Oncology Solutions
82%
Invitrocue
81%

Kiyatec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 13, 2025
StrategicMay 18, 2023
Series CDec 12, 2022
Corporate FundingDec 14, 2021
VC RoundApr 30, 2021
VC Round
Jan 8, 2020

Kiyatec Investors

Notable investors and investment history

Kiyatec investors
InvestorRounds
National Institute of Biomedical Imaging and BioengineeringGrant
National Cancer InstituteGrant
The Sontag FoundationStrategic
Seae VenturesSeries C, VC Round
EsperanteVC Round
SC LaunchSeries A, VC Round
VentureSouthSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 87% MoM.

  • Nov 13, 2025

    Completed a strategic funding round.

Kiyatec Filings

Explore SEC and related filing metadata, where available.

Kiyatec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kiyatec's valuation, stock price, and market status.

Is Kiyatec a public or private company?

Kiyatec is a private company.

What is the current stock price of Kiyatec?

Kiyatec is a private company with no public stock price. No recent secondary market data is available.

How much is Kiyatec worth (valuation)?

Valuation information for Kiyatec is not publicly available.

Can I buy Kiyatec stock?

Kiyatec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kiyatec's last funding round?

Kiyatec's most recent funding round was Strategic on May 18, 2023.

Who are the main investors in Kiyatec?

Key investors in Kiyatec include Seae Ventures, VentureSouth.

Will Kiyatec IPO soon?

No public IPO plans have been announced for Kiyatec.

How can I track Kiyatec secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kiyatec's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGreenville, South Carolina
Employee Range14
Year Founded2005
Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?